Torrent Pharma Inc recalls Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ
Torrent Pharma recalls 100-count Anagrelide Capsules (1 mg) due to failed dissolution specifications. This may affect medication effectiveness. Contact for details.
Lower-risk recall
Failed Dissolution Specifications
Contact the company & request your remedy
What happened, in plain English
Torrent Pharma is recalling 100-count Anagrel: 1 mg capsules that failed dissolution tests. This could mean the medication doesn't work as intended, so affected users should check their prescription details. Read more at govinfonow.com/recall/36651-torrent-pharma-anagrelide-capsules-recall-failed-dissolution-specifications.
Source Summary by GovInfoNow · govinfonow.com/recall/36651-torrent-pharma-anagrelide-capsules-recall-failed-dissolution-specifications · Updated October 4, 2026 · FDA enforcement record: FDA #D-0166-2021
Cite this page
“Torrent Pharma Anagrelide Capsules Recall: Failed Dissolution Specifications.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36651-torrent-pharma-anagrelide-capsules-recall-failed-dissolution-specifications. Based on FDA recall #D-0166-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0166-2021%22&limit=1).
Why it’s dangerous
The capsules failed dissolution specifications, meaning they may not release the medication properly in the body. This could lead to inconsistent dosing or reduced effectiveness. However, the recall does not indicate a risk of serious injury.
Who’s affected
Prescription users of Anagrelide Capsules (1 mg) who received this specific batch from Torrent Pharma. People with conditions requiring this medication are most at risk.
How to tell if you have this one
Check for the NDC code 13668-462-01 and batch number BFD1G001 on the packaging. The capsules were manufactured in India and shipped to the US by Torrent Pharma.
- Brand
Torrent Pharma- Category
Drug
What to do — step by step
Check Your Capsules
Look for the NDC code 13668-462-01 and batch number BFD1G001 on the packaging.
Questions people ask
Is this product safe to use?
The recall states the capsules failed dissolution specifications, which could affect medication effectiveness. However, no serious injury risk is mentioned.
How do I know if I have the recalled product?
Check for NDC code 13668-462-01 and batch number BFD1G001 on the packaging.
What should I do if I have the recalled product?
The recall does not specify a remedy, so contact Torrent Pharma directly for guidance.
Contact Torrent Pharma
We’ve drafted a message you can send Torrent Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0166-2021 — Torrent Pharma Torrent Pharma Hello, I own a Torrent Pharma that is covered by recall D-0166-2021 from Torrent Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0166-2021 (November 25, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0166-2021 to see it in context.
- Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.